Need for dialogue on tobacco harm reduction
For the past four years, Scott Ballin, working with and through a team at the University of Virginia, has hosted a series of what they call Morven Dialogues. These have attracted industry representatives and the handful of public health people known to be supportive of THR and e-cigarettes, but no active participation from FDA, CDC, NIH, AMA, or heart, lung or cancer societies.
The issue I would like to see addressed, both domestically and internationally is this perception that the industry is an evil monolithic enterprise and that there are none within the industry who would sincerely welcome the opportunity to partner with public health colleagues in pursuit of shared public health objectives.